Porsche IPO To Be Priced At Top End Of Expected Range

Shivani Kumaresan
1 min read
0
In this article:

  • Volkswagen AG (OTC: VWAGY) owned luxury sports car brand Porsche AG shares are expected to be priced at the top end of the range in the upcoming listing.

  • The expected range is likely to value the carmaker up to €75 billion ($72 billion), Reuters reported.

  • The luxury car maker’s books were covered multiple times ahead of the IPO on September 29, the report cited bookrunners.

  • Also Read: Porsche To Hire Former Mercedes Executive Amidst Potential IPO Plans

  • Porsche AG is expected to start trading on the Frankfurt stock exchange on September 29.

  • A total of 911 million shares will be divided into 455.5 million preferred shares and 455.5 million ordinary shares.

  • Price Action: VWAGY shares closed lower by 1.43% at $18.33 on Monday.

  • Photo Via Company

See more from Benzinga

Don't miss real-time alerts on your stocks - join Benzinga Pro for free! Try the tool that will help you invest smarter, faster, and better.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Advertisement

Recommended Stories

  • Jeff Bezos' Most Prized Possession Breaks Historical Auction Records At Almost $53 Million

    Jeff Bezos amassed his wealth through Amazon stocks and owns hundreds of millions of dollars worth of real estate, but one of his most valuable possessions may surprise you: art. Among his collection is the renowned piece "Hurting the Word Radio #2 (1964)" by Ed Ruscha, purchased by Bezos for almost $53 million. This artwork, a prime example of Ruscha’s text-based paintings, stands as a signature piece in Bezos’ collection. As concerns over stock market volatility persist, the world’s wealthiest

  • Warren Buffett's Latest $2.6 Billion Buy Brings His Total Investment in This Stock to More Than $77 Billion in Under 6 Years

    The Oracle of Omaha has purchased shares of his favorite stock for 23 consecutive quarters.

  • Nvidia Dethroned: This AI Chip Stock Now Rules This Elite Screen

    Broadcom just ended the reign of Nvidia, usurping the top spot on this list of new buys by the best mutual funds.

  • I Finally Decided to Cut My Losses and Sell This Stock -- Here's Why

    This real estate technology company could be hit hard by a changing real estate market.

  • Chip Workers Are Likely to Quit Jobs, Worsening Labor Shortage

    (Bloomberg) -- At a time when the US is looking to attract more skilled workers to semiconductor manufacturing, many current employees are rethinking whether they want to stick around, according to a McKinsey & Co. report that underscores the chip industry’s labor challenges.Most Read from BloombergElon Musk Pledges to Grow Supercharger Business He Just DecimatedApple Nears Deal With OpenAI to Put ChatGPT on iPhoneBiden Set to Hit China EVs, Strategic Sectors With TariffsJim Simons, Code Breaker

  • With Apple entering the fight, the AI chip wars have gone nuclear

    The AI PC chip wars are going nuclear as Apple officially joins the fight with its M4 processor.

  • McDonald’s Will Offer a $5 Meal Deal to Lure Customers Back Into Stores

    (Bloomberg) -- McDonald’s Corp. is looking to launch a $5 meal deal in the US that the burger chain is betting can lure penny-pinching consumers back in.Most Read from BloombergElon Musk Pledges to Grow Supercharger Business He Just DecimatedApple Nears Deal With OpenAI to Put ChatGPT on iPhoneBiden Set to Hit China EVs, Strategic Sectors With TariffsJim Simons, Code Breaker Who Mastered Investing, Dies at 86Ice Cube’s Big3 Basketball League Sells Its First Team in $10 Million DealThe deal could

  • Bitcoin Is In a 'Bore You to Death' Phase, but Bottom Could Be Close, Analysts Say

    The current boring crypto market could last between one to six months, and the sentiment will be the most negative right before the turnaround, one hedge fund manager said.

  • Macrogenics Stock Drops 77% After Study Deaths

    MacroGenics shares plunged 77.4% on Friday, erasing $773.2 million in market value, after the biotech reported late Thursday that five patients died in a study of the company’s cancer drug. MacroGenics said two of the deaths were deemed unrelated to the drug, known as vobra duo, according to researchers. “The cause and effect with regard to the drug is still being investigated,” Chief Executive Scott Koenig said of the three deaths on the company's first quarter earnings call on Thursday.

  • Tesla’s Autopilot caused a fiery crash into a tree, killing a Colorado man, lawsuit says

    The widow of a man who died after his Tesla veered off the road and crashed into a tree while he was using its partially automated driving system is suing the carmaker, claiming its marketing of the technology is dangerously misleading. The Autopilot system prevented Hans Von Ohain from being able to keep his Model 3 Tesla on a Colorado road in 2022, according to the lawsuit filed by Nora Bass in state court on May 3. Von Ohain died after the car hit a tree and burst into flames, but a passenger was able to escape, the suit says.